Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
BioArctic AB

May 2026

BioArctic AB Market Share Analysis for May 2026

BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments for neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and ALS.
Industry: N/A
Year Founded2003
Employees51 - 200
Annual Revenue$25M - $50M
bioarctic.com
BioArctic AB
BioArctic AB (including company regionals)
  • bioarctic.com
    bioarctic.com
See more website traffic and engagement information

BioArctic AB Revenue up to May 2026 is 25M - 50M

revenue generated by BioArctic AB top domains

BioArctic AB top domains revenue over 3 years

Revenue for BioArctic AB top domains

bioarctic.combioarctic.com25M - 50M
See more with Sales Intelligence

Total visits to BioArctic AB's top domains

Understand BioArctic AB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in BioArctic AB's top domains

Analyze BioArctic AB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on BioArctic AB's top domains

See how BioArctic AB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by BioArctic AB

These are the website technologies, by industry, used by BioArctic AB top domains

Payment & Currencies (3)

PayPal

PayPal

Widget (3)

Twemoji

Twemoji

Conversion & Analytics (2)

Google Analytics

Google Analytics

Mobile (2)

Meta Viewport

Meta Viewport

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from BioArctic AB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioArctic AB is developing potential treatment for neurodegenerative diseases on Jun 1st '26.Lilly recently signed a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to develop a potential treatment for neurodegenerative diseases.
NewsEli Lilly partnered with BioArctic AB on Jun 22nd '26.Eli Lilly and Company (NYSE:LLY) and BioArctic AB announced on June 22 their entry into a research and collaboration agreement regarding a potential new treatment combining BioArctic's proprietary BrainTransporter technology with an undisclosed Lilly drug candidate in neurodegeneration.
NewsBioArctic AB is developing drug candidate.BioArctic will create a new drug candidate using its BrainTransporter platform and Lilly's molecule.

See all BioArctic AB signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.